Functional vision disorder: a review of diagnosis, management and costs.
Brendan Ka-Lok TaoJim Shenchu XieEdward A MargolinPublished in: The British journal of ophthalmology (2024)
Functional vision disorder (FVD) is a relatively common diagnosis in ophthalmic practice which can be difficult to make because of clinician's apprehension to miss organic pathology. We review the diagnostic approach to patients with FVD, organic mimics of FVD, its diagnostic and management strategies and associated cost burden. Patients with FVD typically present with visual acuity and/or field loss. Diagnostic work-up should include patient observation, detailed history, pupillary examination, dilated ophthalmoscopy, visual field testing and ganglion cell analysis of the macular complex. Most common organic mimickers of FVD are amblyopia, cortical blindness, retrobulbar optic neuritis, cone dystrophy and chiasmal tumours; however, all could be ruled out by structured diagnostic approach. For patients with unilateral visual loss, bottom-up refraction, fogging of the well-seeing eye in the phoropter, convex lens and base-down prism tests could aid in diagnosis. For patients claiming binocular vision loss, checking for eye movement during the mirror test or nystagmus elicited by an optokinetic drum can be helpful. Effective management of FVD involves reassurance, stress reduction and, if agreed on, management of comorbid anxiety and/or depression. The social cost of FVD is predominately economic as patients typically meet several healthcare providers over multiple visits and often undergo several neuroimaging studies before neuro-ophthalmology referral. Further, inappropriate granting of disability benefits confers additional stigma to patients with organic vision loss.
Keyphrases
- healthcare
- end stage renal disease
- ejection fraction
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- primary care
- mental health
- stem cells
- hepatitis c virus
- human immunodeficiency virus
- early onset
- physical activity
- social media
- cell therapy
- sleep quality
- patient reported
- hiv aids
- hiv infected
- antiretroviral therapy
- case control